Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 2939

All this and stamp collecting?paraphrase Lord Kelvin.

If you’d like to learn more about quantum mechanics, use our link https://brilliant.org/sabine — You can get started for free, and the first 200 will get 20% off the annual premium subscription.

Correction to what I say at 14:22 — The KATRIN experiment does not look for neutrinoless double beta decay, it’s trying to measure the absolute neutrino masses. There are several other experiments looking for neutrinoless double beta decay. Sorry about that mixup!

Continue reading “New physics or not? I’ll sort it out for you” | >

A team of scientists led by Masaya Hagiwara of RIKEN national science institute in Japan has developed an ingenious device, using layers of hydrogels in a cube-like structure, that allows researchers to construct complex 3D organoids without using elaborate techniques. The group also recently demonstrated the ability to use the device to build organoids that faithfully reproduce the asymmetric genetic expression that characterizes the actual development of organisms. The device has the potential to revolutionize the way we test drugs, and could also provide insights into how tissues develop and lead to better techniques for growing artificial organs.

Scientists have long struggled to create organoids—organ-like tissues grown in the laboratory—to replicate actual biological development. Creating organoids that function similarly to real tissues is vital for developing medicines since it is necessary to understand how drugs move through various tissues. Organoids also help us gain insights into the process of development itself and are a stepping stone on the way to growing whole organs that can help patients.

Read more | >

Teeth don’t grow back once we become adults: any wear and tear is permanent – as those of us with fillings will know – which is why it’s important to keep them as clean and healthy as we can.

However, this is something scientists are now looking to change.

It’s been announced that clinical trials for a potential tooth regrowth treatment are set to begin in July 2024, building on decades of research in the field. If those trials are successful, therapeutic drugs could be available by 2030.

Read more | >

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies.

Read more | >

The advancement of robotics and artificial intelligence (AI) has paved the way for a new era in warfare. Gone are the days of manned ships and traditional naval operations. Instead, the US Navy’s Task Force 59 is at the forefront of integrating AI and robotics into naval operations. With a fleet of autonomous robot ships, the Navy aims to revolutionize the way wars are fought at sea.

The Persian Gulf serves as a testing ground for Task Force 59’s fleet of robot ships. These unmanned vessels, ranging from solar-powered kayaks to surfboard-style boats, are equipped with state-of-the-art technology. Their purpose is to act as the eyes and ears of the Navy, collecting data through cameras, radar, and hydrophones. Pattern-matching algorithms help differentiate between oil tankers and potential threats like smugglers.

One particular vessel, the Triton, stands out with its ability to submerge for extended periods. This feature allows it to evade enemy detection and resurface when it is safe to do so. The Triton can stay submerged for up to five days, utilizing this time to recharge its batteries and transmit valuable information back to base.

Read more | >

X CEO Linda Yaccarino claims that the company formerly known as Twitter is almost breaking even.

“I’ve been at the company eight weeks,” Yaccarino said in her first broadcast interview since taking on her new role. “The operational run rate right now… we’re pretty close to break even.”

This is a surprising declaration, given the company’s financial struggles since its acquisition by Elon Musk. Ad revenue is plummeting as brands pause spending on the platform, and X has gone to desperate lengths to get more cash flow — remember when we all got rate limited for not subscribing to Twitter Blue? Or when the company curbed its developer community by charging exorbitant rates for API access?

Read more | >